Keiko Ikemoto

Title: Keiko Ikemoto: Pioneering Human Cell Line Innovations

Introduction

Keiko Ikemoto, an innovative inventor based in Takarazuka, Japan, has made significant contributions to the field of biochemistry through her patents. By focusing on human cell lines, her work enhances the understanding of drug metabolism and the role of cytochromes P450, which are critical in pharmacology and toxicology studies.

Latest Patents

Ikemoto holds a notable patent titled "Human cell line showing stable expression of cytochromes P450." This invention encompasses cultured cell lines derived from human liver that stably express a series of human cytochromes P450 including CYP1A1, 1A2, 2A6, 2B6, 2C8, 2C9, 2D6, and 3A4. This robust tool is invaluable for analyzing enzymes involved in the metabolism of xenobiotics and endogenous substrates, advancing both research and therapeutic developments.

Career Highlights

Throughout her career, Keiko Ikemoto has demonstrated a dedication to scientific exploration and innovation. Her research has not only contributed to the understanding of metabolic processes but has also paved the way for future advancements in pharmaceutical sciences. With a strong academic foundation and experimental skills, she continues to influence her field significantly.

Collaborations

In her pursuit of innovation, Ikemoto has collaborated with colleagues such as Masayoshi Nanba and Satoru Asahi. These partnerships exemplify the collaborative nature of scientific research, where sharing knowledge and resources leads to groundbreaking discoveries.

Conclusion

Keiko Ikemoto's work in developing human liver-derived cultured cell lines stands as a testament to her commitment to enhancing biomedical research. Her patent and collaborations reflect her significant role as an inventor dedicated to advancing the understanding of drug metabolism, paving the way for future inventions that can improve health outcomes globally.